Home › Funds › HIMENSION CAPITAL (SINGAPORE) PTE. LTD. › NTLA

HIMENSION CAPITAL (SINGAPORE) PTE. LTD. position in NTLA

INTELLIA THERAPEUTICS INC · Health Care

HIMENSION CAPITAL (SINGAPORE) PTE. LTD. reported holding 363,585 shares of NTLA (INTELLIA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$4.4M, representing 0.30% of its reported portfolio and ranking #33 among its reported holdings. HIMENSION CAPITAL (SINGAPORE) PTE. LTD. has disclosed NTLA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)363.58K sh
Reported value held$4.38M
Portfolio Weight0.30%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How HIMENSION CAPITAL (SINGAPORE) PTE. LTD.'s NTLA position evolved

HIMENSION CAPITAL (SINGAPORE) PTE. LTD. first disclosed a stake in NTLA in Q3 2023 at 1,145,091 shares (US$36.2M). Across 13 filings, HIMENSION CAPITAL (SINGAPORE) PTE. LTD. increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 363,585 shares valued at US$4.4M — an increase of 36,692 shares quarter over quarter.. Notable position changes include a 26% trim in Q1 2026 (shares rose 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.15M $36.21M New
Q4 2023 1.03M $31.42M Reduce
Q1 2024 1.03M $28.35M Hold
Q2 2024 1.03M $23.05M Hold
Q3 2024 1.08M $22.11M Add
Q4 2024 985.72K $11.49M Reduce
Q1 2025 752.68K $5.35M Reduce
Q2 2025 729.42K $6.84M Reduce
Q3 2025 565.13K $9.76M Reduce
Q4 2025 578.56K $5.20M Add
Q1 2026 429.54K $5.51M Reduce
Q2 2026 326.89K $5.53M Reduce
Q3 2026 363.58K $4.38M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NTLA and 13F data

NTLA (INTELLIA THERAPEUTICS INC) is a Health Care company. 34 other funds we track also report a position in NTLA — the largest reported positions include ARK Invest (US$192.1M), RA CAPITAL MANAGEMENT, L.P. (US$76.6M), REGENERON PHARMACEUTICALS, INC. (US$44.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NTLA

All NTLA fund holders →

FAQ

How long has HIMENSION CAPITAL (SINGAPORE) PTE. LTD. held NTLA?

HIMENSION CAPITAL (SINGAPORE) PTE. LTD. has disclosed NTLA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is HIMENSION CAPITAL (SINGAPORE) PTE. LTD.'s current position in NTLA?

As of Q3 2026, HIMENSION CAPITAL (SINGAPORE) PTE. LTD. holds 363.58K shares of NTLA (INTELLIA THERAPEUTICS INC), valued at $4.38M, representing 0.30% of its reported portfolio and ranking #33.

Has HIMENSION CAPITAL (SINGAPORE) PTE. LTD. been buying or selling NTLA?

In the latest 13F filing (Q3 2026), HIMENSION CAPITAL (SINGAPORE) PTE. LTD. increased its position in NTLA.

Which other funds hold NTLA?

Other major institutional holders of NTLA include ARK Invest, RA CAPITAL MANAGEMENT, L.P., REGENERON PHARMACEUTICALS, INC., among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.